Combatting antimicrobial-resistant Neisseria gonorrhoeae: new antibiotics and the pipeline of antigonococcal therapeutics
Recent advances in the development of antibiotics, biologics and small molecules against gonorrhea provide optimism against the stark background of multidrug-resistant gonorrhea. Ongoing surveillance remains critical to evaluate the efficacy of newly introduced treatments.
Authors
- Davinder Gill (ORCID: https://orcid.org/0000-0003-1191-3334)
- Peter A. Rice
- Sanjay Ram
Institutions
- University of Massachusetts Chan Medical School (US)
- CuriRx (United States) (US)
Publication Details
- Journal
- Current Opinion in Infectious Diseases
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1097/qco.0000000000001170
- Primary Topic
- Bacterial Infections and Vaccines
- Type
- article
- Field-Weighted Citation Impact
- 0.00